Search

everythinglearnresearchcommunity

for

Search:↓

Low vitamin D might be linked to certain types of hair loss, and supplements could help, but more research is needed.

TrichoScan effectively diagnoses different types of hair loss and is linked to low iron stores in patients.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

The document concludes that accurate diagnosis and appropriate management are crucial for treating various hair disorders, which have significant psychological impacts.

Some drugs can cause serious side effects like heart issues and nervous system problems, but certain drugs for Parkinson's and overactive bladder may be safer, though they still have some common side effects.

Up to half of women by age 50 experience significant hair loss, with various types and treatments available.

Eating disorders can cause hair loss in patients.

Trichodynia is a painful scalp condition not directly linked to the amount or type of hair loss and may involve psychological factors, with treatments showing mixed results.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

A new treatment using stem cell-conditioned media significantly improved hair growth in people with temporary hair loss.

Taking Kera-Diet® improves hair and nail health without side effects.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

Thyroid disease can cause hair loss and treating thyroid problems might help with hair disorders.

Dr. Rodney Sinclair uses a detailed grading system to diagnose female pattern hair loss, recommends daily spironolactone and minoxidil for treatment, and believes genetics play a role in the condition.

Reassurance and counseling are key in managing acute telogen effluvium, with supplements possibly offering a placebo effect.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Hair diseases can have psychological effects and should be treated with a combination of psychosomatic care, therapy, and medication.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Possible link between androgens and COVID-19 severity; more research needed.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

The new visual scale is a quick and effective way to measure hair loss in women.

Midscalp hair density and terminal hair percentage are good indicators of female pattern hair loss severity.

Low vitamin D levels are linked to severe and active alopecia areata.

Androgenetic alopecia negatively affects quality of life and self-esteem, especially in women, but not depression.

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.

Stem cell treatment improved life quality and sexual function in women with hair loss.